Introduction Coronavirus disease of 2019 (COVID-19) has resulted in millions of cases
worldwide. As the pandemic has progressed, the understanding of this disease has evolved …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has become a global epidemic and poses a major …

The most consequential challenge raised by coinfection is perhaps the inappropriate
generation of recombinant viruses through the exchange of genetic material among different …

Background and Aims We compared risk of acute liver injury and mortality in patients with
COVID‐19 and current, past, and no HBV infection. Approach and Results This was a …

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) is spreading at an alarming rate, and it has created …

Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is a novel coronavirus
that causes coronavirus disease 19 (COVID‐19), which has infected millions of people …

The novel mRNA-based vaccines against SARS-CoV-2 display encouraging safety and
efficacy profiles. However, there is a paucity of data regarding their immunogenicity and …

The current frequency of COVID-19 in a pandemic era ensures that co-infections with a
variety of co-pathogens will occur. Generally, there is a low rate of bonafide co-infections in …

The world has made significant progress in develo** novel treatments for COVID-19 since
the pandemic began. Some treatments target the patient's dysregulated inflammatory …

Universal hepatitis B virus (HBV) vaccination has been applied for years in most countries,
but HBV infection remains an unresolved public health problem worldwide, with over one …